Company Filing History:
Years Active: 2023
Title: Kerstin Effenberger: Innovator in RNA Modulation
Introduction
Kerstin Effenberger is a notable inventor based in Metuchen, NJ (US). She has made significant contributions to the field of RNA modulation, holding 2 patents that focus on innovative methods for altering RNA splicing and gene expression.
Latest Patents
Her latest patents include groundbreaking work on "Methods for Modulating RNA Splicing." In one aspect, she describes an intronic recognition element for splicing modifier (iREMS) that can be recognized by a compound provided in her research. This work outlines methods for modulating the amount of a product of a gene, utilizing a precursor RNA transcript that contains an intronic REMS. Furthermore, her patents detail artificial gene constructs that incorporate an intronic REMS, which can be used to modulate protein production. Another patent focuses on methods for modifying RNA splicing to enhance the amount of a gene product, employing a small molecule splicing modifier compound.
Career Highlights
Kerstin Effenberger is currently associated with PTC Therapeutics, Inc., where she continues her research and development in the field of RNA modulation. Her work is pivotal in advancing our understanding of gene expression and its implications for therapeutic applications.
Collaborations
Some of her notable coworkers include Anuradha Bhattacharyya and Amal Dakka, who contribute to her innovative projects and research endeavors.
Conclusion
Kerstin Effenberger's contributions to RNA modulation through her patents and work at PTC Therapeutics, Inc. highlight her role as a leading inventor in the field. Her innovative approaches have the potential to significantly impact genetic research and therapeutic strategies.